Halozyme Therapeutics | HALO - Stock

Aktienkurs
67.82
Täglich Wechseln
0.74 1.10%
Monatlich
2.02%
Jährlich
12.62%
Q2 Prognose
65.97




Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
Amgen USD 6.22B 121M 2025-12
Baxter International USD 2.23B 228M 2025-12
Cara Therapeutics USD 900K 0 2025-03
Cytokinetics USD 0 0 2023-12
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Intrexon USD 287K 68K 2022-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
MannKind USD 35.31M 8.34M 2025-12
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Pfizer USD 11.47B 201M 2025-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vanda Pharmaceuticals USD 1.85M 190K 2025-12